SCHEMBL6469640

SCHEMBL6469640

N#CCOc1cc(F)ccc1-c1ccc(-n2cc(NC(N)=O)c(C(N)=O)n2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5AP P20292 3/20 0.41
FEN1 P39748 3/20 0.41
SCN9A Q15858 3/20 0.37
KDM4E B2RXH2 2/20 0.37
KMT2A Q03164 2/20 0.37
MEN1 O00255 1/20 0.37
ALDH1A1 P00352 1/20 0.37
HTT P42858 1/20 0.37
ITK Q08881 1/20 0.36
MAPT P10636 1/20 0.36
GPR6 P46095 1/20 0.35
GPBAR1 Q8TDU6 1/20 0.35
GRIN1 Q05586 1/20 0.35
GRIN2B Q13224 1/20 0.35
IDO1 P14902 1/20 0.34
TDO2 P48775 1/20 0.34
PARP1 P09874 1/20 0.34
IRAK4 Q9NWZ3 2/20 0.33
NPC1 O15118 1/20 0.33
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6470117 0.94 ALOX5AP (0.39) ALOX5APFEN1SCN9AKDM4EKMT2A
SCHEMBL6498000 0.91 ALOX5AP (0.39) ALOX5APFEN1SCN9AKDM4EKMT2A
SCHEMBL6470404 0.89 GPBAR1 (0.37) ALOX5APFEN1SCN9AALDH1A1ITK
SCHEMBL6503754 0.84 KDM4E (0.42) SCN9AKDM4EKMT2AMEN1ALDH1A1
SCHEMBL6499446 0.84 SCN9A (0.47) ALOX5APFEN1SCN9AKDM4EKMT2A
SCHEMBL6507532 0.83 SCN9A (0.52) ALOX5APFEN1SCN9AITKIRAK4
SCHEMBL6470351 0.82 KDM4E (0.42) SCN9AKDM4EKMT2AMEN1ALDH1A1
SCHEMBL6467409 0.82 FEN1 (0.48) ALOX5APFEN1SCN9AITK
SCHEMBL6504773 0.81 KDM4E (0.38) SCN9AKDM4EKMT2AMEN1ALDH1A1
SCHEMBL6470220 0.81 ITK (0.38) ALOX5APFEN1SCN9AKDM4EKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050197338-A1 Substituted pyrazole urea compounds for the treatment of inflammation PHARMACIA AND UPJOHN COMPANY LLC 2005-09-08 US disclosed
WO-2005037797-A1 SUBSTITUTED PYRAZOLE UREA COMPOUNDS FOR THE TREATMENT OF INFLAMMATION PHARMACIA CORPORATION (US) 2005-04-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050197338-A1 Substituted pyrazole urea compounds for the treatment of inflammation IL4, ARG2, CASP4 ALOX5AP 3501/4885FEN1 3536/4885SCN9A 4159/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.